Beneficial ownership — 13D / 13G
87,339 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| GAMCO INVESTORS, INC. ET AL | GDL Gdl Fund | 13D/A | 23.39% | Mar 8, 2024 | 2y |
| GAMCO INVESTORS, INC. ET AL | GGZ Gabelli Global Small & Mid Cap Value Trust | 13D/A | 31.93% | Mar 8, 2024 | 2y |
| Portolan Capital Management, LLC | INVE INVE Technologies, Inc. | 13G | 5.54% | Mar 6, 2024 | 2y |
| NEEDHAM INVESTMENT MANAGEMENT LLC | TDUP ThredUp Inc. | 13G | 5.45% | Mar 5, 2024 | 2y |
| PERCEPTIVE ADVISORS LLC | DTIL Precision Biosciences Inc | 13G | 7.9% | Mar 5, 2024 | 2y |
| ADAR1 Partners, LP | QTTB Q32 Bio Inc. | 13G | 5.4% | Mar 4, 2024 | 2y |
| Mitchell P. Kopin | BBLG Bone Biologics Corp | 13G | 9.99% | Mar 4, 2024 | 2y |
| Kissei Pharmaceutical Co., Ltd. | CGON CG Oncology, Inc. | 13G | 5.3% | Jan 29, 2024 | 2y |
| Erik E. and Edith H. Bergstrom Foundation | ADX Adams Diversified Equity Fund, Inc. | 13G/A | 5.5% | Dec 31, 2023 | 2y |
| Thomas Meyer | CYTOF Altamira Therapeutics Ltd. | 13D/A | 1.2% | Mar 13, 2024 | 2y |
| VITO GARFI | SQFT Presidio Property Trust, Inc. | 13D/A | 4.1% | Mar 13, 2024 | 2y |
| SIT INVESTMENT ASSOCIATES INC | PIM Franklin Master Intermediate Income Trust | 13D/A | 44.85% | Mar 13, 2024 | 2y |
| 5AM Partners VII, LLC | SKYE Skye Bioscience, Inc. | 13D/A | 40% | Mar 13, 2024 | 2y |
| Kimmeridge Energy Management Company, LLC | SBOW SilverBow Resources, Inc. | 13D/A | 12.9% | Mar 13, 2024 | 2y |
| GAMCO INVESTORS, INC. ET AL | HARP Harpoon Therapeutics, Inc. Common Stock | 13D/A | 0% | Mar 12, 2024 | 2y |
| Deutsche Telekom AG | TMUS T-Mobile US, Inc. | 13D/A | 57.6% | Mar 12, 2024 | 2y |
| Waterton Global Resource Management, Inc. | IAUX i-80 Gold Corp. | 13G/A | 4.6% | Mar 12, 2024 | 2y |
| Saba Capital Management, L.P. | BCAT BlackRock Capital Allocation Term Trust | 13D/A | 15.2% | Mar 12, 2024 | 2y |
| Antofagasta plc | BVN Buenaventura Mining Co Inc | 13D/A | 18.9% | Mar 11, 2024 | 2y |
| Saba Capital Management, L.P. | IGA Voya Global Advantage & Premium Opportunity Fund | 13D/A | 6.78% | Mar 11, 2024 | 2y |
| Saba Capital Management, L.P. | NQP NUVEEN PENNSYLVANIA QUALITY MUNICIPAL INCOME FUND | 13D/A | 12.9% | Mar 11, 2024 | 2y |
| NSV Investments I, L.P. | VTYX Ventyx Biosciences, Inc. Common Stock | 13D/A | 12% | Mar 11, 2024 | 2y |
| Artal International S.C.A. | LXRX Lexicon Pharmaceuticals, Inc. | 13D/A | 47.7% | Mar 11, 2024 | 2y |
| Camac Partners, LLC | ABCP AmBase Corp | 13D/A | 5.5% | Mar 11, 2024 | 2y |
| Don R. Daseke | PROF Profound Medical Corp. | 13G/A | 4.5% | Mar 7, 2024 | 2y |
| STRONG RICHARD S | CVU Cpi Aerostructures Inc | 13G | 5% | Mar 7, 2024 | 2y |
| Juniper Investment Company, LLC | LINC Lincoln Educational Services Corp | 13D/A | 11.4% | Feb 29, 2024 | 2y |
| Denver J. Smith | IVFH Innovative Food Holdings Inc | 13D/A | 8.1% | Dec 31, 2023 | 2y |
| AbbVie Biotechnology Ltd. | CARM Carisma Therapeutics Inc. | 13G | 6.8% | Dec 31, 2023 | 2y |
| DANIEL E. STONE | SCNI Scinai Immunotherapeutics Ltd. | 13D | 12.96% | Mar 12, 2024 | 2y |
| GAMCO INVESTORS, INC. ET AL | INVX Innovex International, Inc. | 13D/A | 6.38% | Mar 11, 2024 | 2y |
| GAMCO INVESTORS, INC. ET AL | CYT Cyteir Therapeutics, Inc. Common Stock | 13D/A | 4.2% | Mar 11, 2024 | 2y |
| George P. Bauer | ASLE AerSale Corp | 13D/A | 7.5% | Mar 11, 2024 | 2y |
| Saba Capital Management, L.P. | GRX Gabelli Healthcare & WellnessRx Trust | 13G | 5.1% | Mar 8, 2024 | 2y |
| CYRUS CAPITAL PARTNERS, L.P. | ICMB Investcorp Credit Management BDC, Inc. | 13D/A | 4.7% | Mar 8, 2024 | 2y |
| Warren B. Kanders | CLAR Clarus Corp | 13D/A | 16.7% | Mar 8, 2024 | 2y |
| Fund 1 Investments, LLC | CTRN Citi Trends Inc | 13D/A | 18.1% | Mar 8, 2024 | 2y |
| JAB BevCo B.V. | KDP Keurig Dr Pepper Inc. | 13D/A | 21.9% | Mar 8, 2024 | 2y |
| Greenhaven Road Investment Management, L.P. | PAR Par Technology Corp | 13G | 5.9% | Mar 7, 2024 | 2y |
| Pinetree Capital Ltd. | TBRG TruBridge, Inc. | 13D | 7.5% | Mar 5, 2024 | 2y |
| Richard L. Soloway | NSSC Napco Security Technologies, Inc | 13D/A | 4.8% | Mar 5, 2024 | 2y |
| Kent Lake Capital LLC | MDRX Veradigm Inc. Common Stock | 13G | 5.54% | Mar 1, 2024 | 2y |
| Davidson Kempner Capital Management LP | VCSA Vacasa, Inc. Class A Common Stock | 13G | 8.06% | Feb 29, 2024 | 2y |
| Haim Shani | CLBT Cellebrite DI Ltd. | 13G/A | 10.8% | Dec 31, 2023 | 2y |
| STOCK YARDS BANK & TRUST CO | SYBT Stock Yards Bancorp, Inc. | 13G/A | 5.2% | Dec 31, 2023 | 2y |
| Standard General L.P. | BALY Bally's Corp | 13D/A | 23.2% | Mar 11, 2024 | 2y |
| Independence Energy Aggregator L.P. | CRGY Crescent Energy Co | 13D/A | 25.4% | Mar 11, 2024 | 2y |
| ORBIMED ISRAEL BIOFUND GP LIMITED PARTNERSHIP | CMMB Chemomab Therapeutics Ltd. | 13D/A | 16% | Mar 11, 2024 | 2y |
| MERCK & CO., INC. | PAND Pandion Therapeutics Inc. Common Stock | 13D/A | 100% | Mar 11, 2024 | 2y |
| Jacobsen Per A. | BLIN Bridgeline Digital, Inc. | 13G/A | 7.2% | Mar 8, 2024 | 2y |